Anaphylaxis and Allergic Reaction – Pediatric

Criteria

  • Anaphylaxis is a rapidly progressing, life-threatening allergic reaction, not simply a rash or hives

All levels

  • Allow the patient to maintain position of comfort
  • Do not force the child to lie down
  • Do not agitate the child
  • Airway management and appropriate oxygen therapy
  • Ongoing assessment of the effectiveness of breathing
  • See Respiratory Arrest / Failure – Pediatric as necessary
  • See Dif Breathing – Pediatric: Stridor as necessary
  • If severe respiratory distress, facial or oral edema, and/or hypoperfusion
  • OR
  • If patient has a history of anaphylaxis and has an exposure to an allergen developing respiratory distress and/or hypoperfusion and/or rash:
  • Epinephrine (1 mg/mL) 0.3 mg IM if ≥30 kg‡¹
  • Epinephrine (1 mg/mL) 0.15 mg IM if <30 kg‡²,³
  • If the patient does not improve within 5 minutes, may repeat once

EMT and up

  • If wheezing, Albuterol⁴ 2.5 mg via nebulizer; may repeat to a total of three doses‡
  • May be combined with Ipratropium (Atrovent) 0.5 mg in 2.5 mL (unit dose)‡

CC and up

  • Diphenhydramine (Benadryl) 1 mg/kg IM; max dose 50 mg

Paramedic

  • Vascular access, if indicated (Resources: Vascular Access)
  • Normal Saline 20 mL/kg IV bolus
  • For signs of allergic reaction, including, but not limited to rash, itching, nausea, etc, consider:
  • Diphenhydramine (Benadryl) 1 mg/kg IM/IV; max total dose 50 mg
  • Dexamethasone (Decadron) 10 mg PO, IM, or IV for patients ≥2 years old

Medical control

  • CC vascular access
  • Epinephrine for indications other than those above
  • Additional Albuterol
  • Epinephrine 0.1-1.5 mcg/kg/minute IV dripⓟ
  • Start at 0.1 mcg/kg/minute, titrate gradually; max 1.5 mcg/kg/minute
  • Dexamethasone (Decadron) 0.6 mg/kg PO, IM, or IV for patients <2 years old

Key points

  • 1. Epinephrine 0.3 mg may be administered via Adult Autoinjector (CFR or higher) or Syringe Epi Kit (EMT or higher)
  • 2. Epinephrine 0.15 mg may be administered via Pediatric Autoinjector (CFR or higher) or Syringe Epi Kit (EMT or higher)
  • 3. Infant Auto Injector (0.1 mg IM) may be substituted for pediatric patients <15 kg, if available (CFR or higher)
  • 4. A combination unit dose (such as a DuoNeb®) may be substituted for Albuterol 2.5 mg in 3 mL (unit dose) & Ipratropium (Atrovent) 0.5 mg in 2.5 mL (unit dose) mixed together
  • If Epinephrine is administered by crew or patient self-administered Epinephrine, regional procedure may require consulting medical control prior to honoring a request for refusal of medical care
  • Though a previous history of anaphylaxis is an important indicator for treatment, providers should be aware that anaphylaxis may develop in patients with no prior history
  • Anaphylaxis may present with shock associated only with GI symptoms. In the setting of a known exposure to an allergen associated with shock, where the presenting symptom is nausea, vomiting, abdominal pain, and/or diarrhea, consider anaphylaxis in consult with medical control.